Dayvigo Tablet, Film Coated
RxNorm Crosswalk NDC 62856-405

View RxNorm Concepts, RxCUIs, and Term Type mappings for this NDC

RxNorm Mapping Clinical Concepts

This drug is included in the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States.

The product Dayvigo (NDC 62856-405) is cross-mapped to the RxNorm terminology system to ensure clinical interoperability. This product is associated with 4 unique RxNorm concepts. By anchoring Eisai Inc.'s product data to these standardized identifiers, healthcare systems can maintain accurate medication records, safely automate e-prescribing, and streamline pharmacy workflows.

The following clinical concept cards detail the semantic term types (TTY), prescribable names, and synonymous clinical strings as defined by the National Library of Medicine (NLM).

SCD
Lemborexant 5 mg Oral Tablet
PSN
DAYVIGO 5 mg Oral Tablet
SCD
Lemborexant 10 mg Oral Tablet
PSN
DAYVIGO 10 mg Oral Tablet
SCDPrescribable
Featured Concept

lemborexant 5 MG Oral Tablet
(RxCUI 2272408)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

Mapped Terms
PSNPrescribable
lemborexant 5 MG Oral Tablet
Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
PSNPrescribable
Featured Concept

DAYVIGO 5 MG Oral Tablet
(RxCUI 2272414)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

Mapped Terms
SBDPrescribable
lemborexant 5 MG Oral Tablet [Dayvigo]
Semantic Branded Drug
Ingredient + Strength + Dose Form + Brand Name
SYPrescribable
Dayvigo 5 MG Oral Tablet
Synonym
Synonym of another TTY, given for clarity.
SCDPrescribable
Featured Concept

lemborexant 10 MG Oral Tablet
(RxCUI 2288425)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

Mapped Terms
PSNPrescribable
lemborexant 10 MG Oral Tablet
Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
PSNPrescribable
Featured Concept

DAYVIGO 10 MG Oral Tablet
(RxCUI 2288427)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

Mapped Terms
SBDPrescribable
lemborexant 10 MG Oral Tablet [Dayvigo]
Semantic Branded Drug
Ingredient + Strength + Dose Form + Brand Name
SYPrescribable
Dayvigo 10 MG Oral Tablet
Synonym
Synonym of another TTY, given for clarity.

Understanding RxNorm Mapping for Dayvigo

RxNorm is a normalized naming system developed by the National Library of Medicine (NLM) to bridge the gap between different drug terminologies. By mapping NDC 62856-405 to RxCUI 2272408, 2272414, 2288425, 2288427, this page provides the standardized "source of truth" required for hospital systems, e-prescribing software, and pharmacy benefit managers (PBMs) to communicate without errors.

Term Type (TTY) Legend for This Page

The clinical cards above utilize specific Term Types (TTY) to define the granularity of the drug concept:

  • PSN Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.
  • SCD Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
  • SBD Semantic Branded Drug: The branded equivalent representing the Brand Name + Strength + Dosage Form.
  • SY Synonym: An alternative clinical name or alias provided for search and retrieval clarity.

* Please review the full disclaimer at the bottom of this page.